MedTrace Logo

HYPOCHOL : A Genetically-based Strategy to Identify New Targets in Cholesterol Metabolism

NCT02354079 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 435

Last updated 2026-04-29

No results posted yet for this study

Summary

The aim of this study is to identify new targets in cholesterol metabolism thanks to a genetically-based strategy.

Conditions

  • Hypobetalipoproteinemia

Interventions

GENETIC

hypobetalipoproteinemia genetic and genotypic screening

Sponsors & Collaborators

  • Nantes University Hospital

    lead OTHER

Principal Investigators

  • Charlotte AUTHIER, Doctor · Health Care Centers of French Health Insurance in Saint-Nazaire

  • Didier GOXE · Health Care Centers of French Health Insurance in La Roche sur Yon

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-07
Primary Completion
2022-01-07
Completion
2032-01-07

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02354079 on ClinicalTrials.gov